Thalamic atrophy and cognition in multiple sclerosis
- PMID: 17875909
- DOI: 10.1212/01.wnl.0000276992.17011.b5
Thalamic atrophy and cognition in multiple sclerosis
Abstract
Objectives: Recent studies have indicated that brain atrophy is more closely associated with cognitive impairment in multiple sclerosis (MS) than are conventional MRI lesion measures. Enlargement of the third ventricle shows a particularly strong correlation with cognitive impairment, suggesting clinical relevance of damage to surrounding structures, such as the thalamus. Previous imaging and pathology studies have demonstrated thalamic involvement in MS. In this study, we tested the hypothesis that thalamic volume is lower in MS than in normal subjects, and that thalamic atrophy in MS correlates with cognitive function.
Methods: We studied 79 patients with MS and 16 normal subjects. A subgroup of 31 MS subjects underwent cognitive testing. The thalamus was segmented in whole from three-dimensional MRI scans. We also determined whole brain atrophy (brain parenchymal fraction), third ventricular width, and whole brain T2-weighted (fluid-attenuated inversion recovery) hyperintense, T1 hypointense, and gadolinium-enhanced lesion volumes.
Results: Normalized thalamic volume was 16.8% lower in the MS group (p < 0.0001) vs controls. Cognitive performance in all domains was moderately to strongly related to thalamic volume in the MS group (r = 0.506 to 0.724, p < 0.005), and thalamic volume entered and remained in all regression models predicting cognitive performance. Thalamic volume showed a weak relationship to physical disability score (r = -0.316, p = 0.005).
Conclusion: These findings suggest that thalamic atrophy is a clinically relevant biomarker of the neurodegenerative disease process in multiple sclerosis.
Similar articles
-
Prediction of neuropsychological impairment in multiple sclerosis: comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden.Arch Neurol. 2004 Feb;61(2):226-30. doi: 10.1001/archneur.61.2.226. Arch Neurol. 2004. PMID: 14967771 Clinical Trial.
-
Neocortical atrophy, third ventricular width, and cognitive dysfunction in multiple sclerosis.Arch Neurol. 2006 Sep;63(9):1301-6. doi: 10.1001/archneur.63.9.1301. Arch Neurol. 2006. PMID: 16966509
-
Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.Mult Scler. 2009 Jul;15(7):779-88. doi: 10.1177/1352458509105544. Mult Scler. 2009. PMID: 19542262
-
MRI markers of destructive pathology in multiple sclerosis-related cognitive dysfunction.J Neurol Sci. 2006 Jun 15;245(1-2):111-6. doi: 10.1016/j.jns.2005.07.014. Epub 2006 Apr 19. J Neurol Sci. 2006. PMID: 16626748 Review.
-
MRI correlates of cognitive dysfunction in multiple sclerosis patients.J Neurovirol. 2000 May;6 Suppl 2:S172-5. J Neurovirol. 2000. PMID: 10871808 Review.
Cited by
-
Altered regional cerebral blood flow in obstructive sleep apnea is associated with sleep fragmentation and oxygen desaturation.J Cereb Blood Flow Metab. 2021 Oct;41(10):2712-2724. doi: 10.1177/0271678X211012109. Epub 2021 Apr 28. J Cereb Blood Flow Metab. 2021. PMID: 33906511 Free PMC article.
-
The Contribution of Cortical Lesions to a Composite MRI Scale of Disease Severity in Multiple Sclerosis.Front Neurol. 2016 Jun 29;7:99. doi: 10.3389/fneur.2016.00099. eCollection 2016. Front Neurol. 2016. PMID: 27445966 Free PMC article.
-
Exploring the Potential of the Corpus Callosum Area as a Predictive Marker for Impaired Information Processing in Multiple Sclerosis.J Clin Med. 2023 Nov 6;12(21):6948. doi: 10.3390/jcm12216948. J Clin Med. 2023. PMID: 37959412 Free PMC article.
-
Toward a better understanding of brain lesions during metachromatic leukodystrophy evolution.AJNR Am J Neuroradiol. 2012 Oct;33(9):1731-9. doi: 10.3174/ajnr.A3038. Epub 2012 Apr 26. AJNR Am J Neuroradiol. 2012. PMID: 22538069 Free PMC article.
-
Regional white matter atrophy--based classification of multiple sclerosis in cross-sectional and longitudinal data.AJNR Am J Neuroradiol. 2009 Oct;30(9):1731-9. doi: 10.3174/ajnr.A1659. Epub 2009 Aug 20. AJNR Am J Neuroradiol. 2009. PMID: 19696139 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical